Double Carbapenem as Rescue Strategy for the Treatment of Carbapenemase-Producing Klebsiella Pneumoniae Infections

Incidence and Risk Factors for Developing Infections in Patients Colonized by CP-KPC

NCT05492539 ·Status: UNKNOWN

Comparison of Bloodstream Infections With Carbapenem Hetero-resistant vs Carbapenem Resistant Klebsiella Pneumoniae

NCT04229498 ·Status: UNKNOWN

Turkish Prospective Cohort Study on Carbapenem Resistant Klebsiella Pneumonia Bacteremia

NCT03597841 ·Status: COMPLETED

Epidemiology of Klebsiella Pneumoniae in China

NCT03598543 ·Status: UNKNOWN

Impact of Imipenem With Amikacin Pharmacokinetic and Pharmacodynamic

NCT00950222 ·Status: COMPLETED ·Phase: NA

Analysis on the Infection Risk, Prognosis, and Drug Sensitivity of Klebsiella Pneumoniae.

NCT04337840 ·Status: UNKNOWN

SDD for Eradicating CRKP Carriage

NCT01761487 ·Status: UNKNOWN ·Phase: PHASE4

Temocillin Versus Carbapenems for Urinary Tract Infection Due to ESBL-producing Enterobacteriaceae

NCT04671290 ·Status: COMPLETED

Dose Optimization by Pharmacokinetic/Pharmacodynamic of Antibiotics to Improve Clinical Outcome of Carbapenem Resistant Klebsiella Pneumoniae Bloodstream Infections in Critically Ill Patients at Phramongkutklao Hospital

NCT05862402 ·Status: UNKNOWN ·Phase: PHASE4

Imipenem/Cilastatin/Relebactam (IMI/REL) in Treatment of CRE Infections

NCT04785924 ·Status: WITHDRAWN ·Phase: PHASE4

Beta-lactams Therapeutic Drug Monitoring in Critically Ill Patients

NCT05352997 ·Status: COMPLETED

A Post-Marketing Study to Assess the Efficacy and Safety of Intravenous Polymyxin B and Colistin Methanesulfonate in Patients With Carbapenem-Resistant Gram-Negative Bacterial Infection

NCT06966284 ·Status: RECRUITING

Development of Risk Score Model and Decision Tree Algorithm for Predicting Infections With CRKp in Colonized Patients

NCT04229511 ·Status: UNKNOWN

Bolus Versus Continuous Infusion of Meropenem

NCT03452839 ·Status: COMPLETED ·Phase: PHASE4

Daptomycin Pharmacokinetics in Critically Ill Patients Undergoing Continuous Veno-venous Hemodiafiltration, a Dose Finding Study

NCT01212432 ·Status: UNKNOWN ·Phase: PHASE2

Piperacillin-tazobactam and Temocillin as Carbapenem-alternatives for the Treatment of Severe Infections Due to Extended-spectrum Beta-lactamase-Producing Gram-negative Enterobacteriaceae in the Intensive Care Unit

NCT05565222 ·Status: RECRUITING ·Phase: PHASE3

Evaluation of the Role of Acetyl Cysteine in Ventilator Associated Pneumonia by Carbapenem Resistance Klebsiella

NCT07097727 ·Status: COMPLETED ·Phase: PHASE1

Epidemiological, Clinical, Microbiological and Outcome Description of Patients With Klebsiella sp Meningitis

NCT03967210 ·Status: COMPLETED

Polymyxin B Monotherapy vs Combination Therapy in Critically Ill Patients With Multi-drug Resistant Pathogens

NCT03159078 ·Status: UNKNOWN ·Phase: PHASE3

Efficacy of Intestinal Decontamination in Patients Colonized by Carbapenem-resistant Klebsiella Pneumoniae and Colistin

NCT02604849 ·Status: COMPLETED

A Retrospective Study on Personalized Dosing Strategy of Patients Treated by Carbapenems: 2018-2021

NCT05762094 ·Status: UNKNOWN

Evaluation of the Non-inferiority of Cefoxitin Versus Imipenem/Cilastatin in the Treatment of Urinary Tract Infections Caused by ESBL-producing Escherichia Coli

NCT02474706 ·Status: TERMINATED ·Phase: PHASE4

Carbapenem and Quinolone Resistance in Klebsiella Pneumoniae

NCT03767283 ·Status: UNKNOWN

PREdiction of CEphalosporinase Producing Enterobacteria During Ventilator-associated Pneumonia for Therapeutic Stewardship

NCT05486130 ·Status: UNKNOWN

Safety, Tolerability, Efficacy and Pharmacodynamics of CAL02 in Severe Pneumonia Caused by Streptococcus Pneumoniae

NCT02583373 ·Status: COMPLETED ·Phase: PHASE1